AXYX

Axonyx (AXYX)

Axonyx

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AXYX

1 2 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2006/09/29	05 : 15	Business Wire	Axonyx Stockholders Approve Merger with TorreyPines Therapeutics Inc.	NASDAQ:AXYX	Axonyx
2006/09/22	00 : 00	PR Newswire (US)	TorreyPines Therapeutics to Present at the UBS Global Life Sciences Conference	NASDAQ:AXYX	Axonyx
2006/08/31	00 : 00	PR Newswire (US)	TorreyPines Therapeutics to Present at the Thomas Weisel Partners 2006 Healthcare Conference	NASDAQ:AXYX	Axonyx
2006/08/08	21 : 30	Business Wire	AXONYX Inc. Announces Second Quarter 2006 Financial Results	NASDAQ:AXYX	Axonyx
2006/08/07	22 : 30	PR Newswire (US)	TorreyPines Therapeutics Initiates Phase I Clinical Trial of NGX426, a Novel Oral Therapy for Migraine and Neuropathic Pain	NASDAQ:AXYX	Axonyx
2006/08/05	05 : 30	Business Wire	Axonyx Receives Notice Related to Nasdaq Minimum Bid Price Rule	NASDAQ:AXYX	Axonyx
2006/07/24	22 : 30	PR Newswire (US)	TorreyPines Therapeutics Completes Second Phase I Study for NGX267, a Selective M1 Agonist for the Treatment of Alzheimer's Dis	NASDAQ:AXYX	Axonyx
2006/06/21	00 : 00	PR Newswire (US)	TorreyPines Therapeutics to Present at the Jefferies & Company Life Sciences Conference	NASDAQ:AXYX	Axonyx
2006/06/10	00 : 34	PR Newswire (US)	TorreyPines Therapeutics to Present at the 2006 Pacific Growth Equities Life Sciences Growth Conference	NASDAQ:AXYX	Axonyx
2006/06/08	21 : 00	Business Wire	Axonyx and TorreyPines to Host Webcast and Conference Call on Announced Merger	NASDAQ:AXYX	Axonyx
2006/06/08	19 : 30	Business Wire	Axonyx and TorreyPines Therapeutics Announce Merger Agreement; Transaction Creates Robust Portfolio in the CNS Disease Area	NASDAQ:AXYX	Axonyx
2006/05/16	05 : 15	Business Wire	Axonyx Announces Completion of the Multiple-Dose Phase I Study of Posiphen(TM)	NASDAQ:AXYX	Axonyx
2006/05/11	06 : 30	Business Wire	Axonyx Inc. Reports First Quarter 2006 Financial Results	NASDAQ:AXYX	Axonyx
2006/05/09	22 : 28	Business Wire	Axonyx to Present at the Rodman & Renshaw 3rd Annual Global Healthcare Conference; Presentation to be Web Cast Live on Corporat	NASDAQ:AXYX	Axonyx
2006/04/24	21 : 30	Business Wire	Researcher Reports Data on Effects of Posiphen(TM) on Human Neuronal Stem Cells; Posiphen May Support Stem Cell Transplantation	NASDAQ:AXYX	Axonyx
2006/04/21	05 : 30	Business Wire	Axonyx Reports Data on Effects of Phenserine on the Brains of Alzheimer's Disease Patients; PET Scans Show Increased Brain Neur	NASDAQ:AXYX	Axonyx
2006/04/20	05 : 30	Business Wire	Axonyx Reports Data on Stabilized Brain Volumes in Alzheimer's Disease Patients Treated with Phenserine; Analysis of Brain Scan	NASDAQ:AXYX	Axonyx
2006/03/17	06 : 15	Business Wire	Axonyx Reports Fourth Quarter and Full Year 2005 Financial Results	NASDAQ:AXYX	Axonyx
2006/03/09	06 : 24	Business Wire	Axonyx Regains Compliance with Nasdaq Minimum Bid Price Rule	NASDAQ:AXYX	Axonyx
2006/02/23	22 : 33	Business Wire	Axonyx to Present at the Wall Street Analyst Forum; Presentation to be Web Cast Live on Corporate Web Site	NASDAQ:AXYX	Axonyx
2006/02/14	22 : 33	Business Wire	Axonyx Reports Phenserine Associated with Significant Amyloid Reduction in Phase I Trial; Results Support Dual Mechanisms of Act	NASDAQ:AXYX	Axonyx
2006/02/07	23 : 00	Business Wire	Axonyx to Present at BIO CEO & Investor Conference 2006; Presentation to be Web Cast Live on Corporate Web Site	NASDAQ:AXYX	Axonyx
2006/01/31	22 : 30	Business Wire	Axonyx Announces Acceptance of Four Abstracts Highlighting Phenserine and Posiphen by the 9th International Geneva/Springfield S	NASDAQ:AXYX	Axonyx
2006/01/24	22 : 30	Business Wire	Axonyx Completes First Phase I Trial with Posiphen for Alzheimer's Disease Progression	NASDAQ:AXYX	Axonyx
2006/01/04	22 : 30	Business Wire	Axonyx Announces License of Phenserine to Daewoong Pharmaceutical Company for South Korea	NASDAQ:AXYX	Axonyx
2005/11/09	22 : 30	Business Wire	Axonyx Inc. Announces Third Quarter Financial Results	NASDAQ:AXYX	Axonyx
2005/11/08	06 : 47	Business Wire	Axonyx Provides Update on Clinical Development Program and Strategic Initiatives	NASDAQ:AXYX	Axonyx
2005/10/26	21 : 00	Business Wire	Axonyx to Present at Rodman & Renshaw Techvest 7th Annual Healthcare Conference; Presentation to Be Web Cast Live on Corporate W	NASDAQ:AXYX	Axonyx
2005/09/20	22 : 00	Business Wire	Axonyx Announces Results of Curtailed Phase III Clinical Trials for Phenserine in Alzheimer's Disease	NASDAQ:AXYX	Axonyx
2005/09/15	21 : 30	Business Wire	Axonyx to Present at the UBS 2005 Global Life Sciences Conference; Presentation to be Web Cast Live on Corporate Web Site	NASDAQ:AXYX	Axonyx